Trials / Sponsors / ImmuneSensor Therapeutics Inc.
ImmuneSensor Therapeutics Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies Type 1 Interferonopathies | Phase 1 | 2026-01-12 |
| Active Not Recruiting | A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial Solid Tumor, Adult | Phase 1 | 2023-09-15 |
| Terminated | Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies Oligoprogressive | Phase 2 | 2023-07-07 |
| Terminated | Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC Oligometastatic Disease | Phase 2 | 2023-06-28 |
| Completed | Safety and Efficacy Study of IMSA101 in Refractory Malignancies Solid Tumor, Adult | Phase 1 / Phase 2 | 2019-09-23 |